Houston, TX, United States of America

Yiyu Zou

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • Houston, TX (US) (1999 - 2007)
  • Bronx, NY (US) (2015)

Company Filing History:


Years Active: 1999-2015

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yiyu Zou: Innovator in Cancer Treatment

Introduction

Yiyu Zou is a prominent inventor based in Houston, TX (US), known for his significant contributions to cancer treatment through innovative formulations. With a total of 4 patents, his work focuses on developing advanced methods and compositions that enhance the efficacy of cancer therapies.

Latest Patents

One of Zou's latest patents involves methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally. This invention relates to administering a cancer-treating effective amount of a composition that includes a lipid-complexed platinum compound, with a concentration greater than about 1.2 mg/ml. Another notable patent is for submicron liposome suspensions obtained from preliposome lyophilizates. This invention provides a method for preparing a stable liposome formulation of the non-cross-resistant anthracycline Annamycin, optimizing the lipid composition and enhancing the reconstitution process.

Career Highlights

Throughout his career, Yiyu Zou has worked with esteemed organizations such as the University of Texas System and Insmed Incorporated. His research and innovations have significantly impacted the field of cancer treatment, showcasing his dedication to improving patient outcomes.

Collaborations

Zou has collaborated with notable colleagues, including Roman Perez-Soler and Waldemar Priebe, contributing to the advancement of cancer treatment methodologies.

Conclusion

Yiyu Zou's innovative work in cancer treatment exemplifies the importance of research and development in the medical field. His patents and collaborations reflect a commitment to enhancing therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…